Ancora Advisors’s Enfusion, Inc. ENFN Stock Holding History

Ancora Advisors’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25	Closed	–	–	2076
2022 Q4	$0	Hold	25	–	–	﹤0.01%	2000
2022 Q3	$0	Buy	+25	New	+$305	﹤0.01%	2206

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Ancora Advisors's ENFN Position: Q1 2023 in Review

Ancora Advisors sold out of Enfusion, Inc. (ENFN) in Q1 2023, closing a stake of 25 shares.

Ancora Advisors first reported a position in ENFN in Q3 2022 and held it in 2 quarters. The position peaked at $0 in Q4 2022. 90 funds tracked by Wall St. Rank hold ENFN as of Q1 2023.

Ancora Advisors reported no remaining Enfusion, Inc. position as of Q1 2023 after selling out during the quarter.
Ancora Advisors sold 25 Enfusion, Inc. shares in Q1 2023.
Ancora Advisors first reported a position in Enfusion, Inc. in Q3 2022 and held it in 2 quarters.
Ancora Advisors's Enfusion, Inc. position peaked at $0 in Q4 2022.
90 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2023.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.